Progress in Cardiovascular Diseases

Proud to share that @PCVDJournal has achieved an Impact Factor of 10.6, ranking #15 among 237 cardiovascular journals worldwide. This remarkable milestone reflects the dedication of our authors, reviewers, editorial board members, and readers who continue to advance the field through high-quality scholarship and scientific rigor. We are especially grateful for the extraordinary leadership of the former EIC @CarlLavie31733, whose vision, commitment to excellence, and many years of service helped build the journal into the highly respected publication it is today. This achievement stands on the strong foundation he created. As we celebrate this accomplishment, we remain committed to publishing impactful reviews, top-quality original research and advancing knowledge that improves cardiovascular health worldwide. Thank you to everyone who has contributed to this success. The future of PCVD is bright. sciencedirect.com/journal/progre…

🆕CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in ischemic dilated CardioMyopathy: Prognostic implication of papillary muscles involvement 🔗 sciencedirect.com/science/articl… @GiuseppeMuscog @gpontone1 #cardioX #cardioTwitter #cardiology